wegovy novo nordisk - Search News

News

Novo Nordisk shares dip further

Novo Nordisk shares dip further as Wegovy gains nearly erased

By Jacob Gronholt-Pedersen (Reuters) -Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later in the session, extending recent losses that threaten to wipe out all the gains since the drugmaker launched its blockbuster weight-loss treatment Wegovy four years ago.

CNBC on MSN · 3d

Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its Wegovy obesity drug in the key U.S. market. Shares were down 17% at 12:30 p.m. London time, shortly after the announcement (7:30 a.m. ET).

QuickTake on MSN · 15h

How Novo Nordisk Gave Up Its Weight-Loss Gains

How did Novo lose its edge in the weight-loss market? Novo was a first mover when it comes to so-called GLP-1 treatments, which cause weight loss by mimicking the appetite-control

3don MSN

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...

Novo Nordisk stock posts worst week since 2021, but analysts see a bigger problem ahead

Novo Nordisk stock plunges 30% after forecast cut, CEO shakeup, and rising competition hit investor confidence.

Devdiscourse13h

Novo Nordisk's Market Rollercoaster: The Weighty Impact of Price Pressure

Novo Nordisk's shares have experienced a significant decline due to increasing competition and pressure from the U.S.

2don MSN

Novo Nordisk slides further on US competition, new CEO concerns

Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts warned of persistent competition from copycat drugs ...

Novo Nordisk Shares Post Worst Ever Week as Optimism Wanes

Just six weeks ago, things seemed to be getting better for Novo Nordisk A/S. Investors were optimistic, and the Danish drugmaker was briefly Europe’s most valuable public company again. Now, the stock ...

WSKG2d

Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

WFRV Local 5 on MSN8h

New tariffs could raise prices of Ozempic, Wegovy

Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...

1don MSN

Why Novo Nordisk Stock Crumbled Again Today

Kumar now believes the stock is only worthy of a hold recommendation, down from his previous assessment of buy. He also significantly lowered his price target, chopping it to 360 Danish krone ($55.49) ...

24/7 Wall St.3d

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

14h

Can I take Wegovy while pregnant?

Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results